₹4.50
(Market cap
₹1,070 Cr
Recently Viewed
Clear AllMarket cap
₹1,070 Cr
Revenue (TTM)
₹414 Cr
P/E Ratio
52.6
P/B Ratio
1.7
Div. Yield
0 %
Value Research Rating
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹20 Cr
ROE
4.8 %
ROCE
7 %
Industry P/E
33.84
EV/EBITDA
10
Debt to Equity
0.5
Book Value
₹118.7
EPS
₹4
Face value
2
Shares outstanding
53,206,281
CFO
₹559.72 Cr
EBITDA
₹736.01 Cr
Net Profit
₹402.15 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tarsons Products
| -13.8 | 3.5 | -9.2 | -42.9 | -28.9 | -- | -- |
|
BSE Healthcare
| -2.1 | -2.7 | -2.2 | 5.2 | 22.9 | 13.5 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Tarsons Products
| -42.5 | -23.5 | -24.1 | 7.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tarsons Products
|
201.1 | 1,070.0 | 414.3 | 20.3 | 8.0 | 3.4 | 52.6 | 1.7 |
| 832.0 | 1,483.1 | 77.0 | 16.4 | -- | 43.4 | 93.9 | 13.8 | |
| 232.2 | 450.3 | 135.7 | 16.1 | -- | 36.8 | 27.9 | 7.0 | |
| 1,724.3 | 28,366.1 | 6,112.8 | 847.2 | 17.2 | 9.2 | 33.5 | 2.9 | |
| 190.4 | 1,049.0 | 264.6 | 19.3 | 8.9 | 6.2 | 45.3 | 4.6 | |
| 868.7 | 10,425.6 | 6,537.7 | 207.0 | 4.6 | 11.5 | 50.4 | 5.5 | |
| 1,453.1 | 14,721.0 | 1,781.6 | 341.3 | 19.8 | 12.4 | 42.3 | 4.9 | |
| 417.3 | 500.8 | 71.3 | 19.8 | 31.4 | 17.9 | 25.3 | 4.2 | |
| 2.6 | 19.4 | 0.2 | -1.9 | -416.2 | -19.8 | -- | 2.2 | |
| 375.1 | 485.5 | 18.6 | 25.3 | -9.9 | -10.2 | -- | 0.6 |
3 min read•By Karthik Anand Vijay
Tarsons Products IPO: How good is it?
6 min read•By Udhayaprakash and Karthik Anand Vijay
Tarsons Products IPO: Information analysis
4 min read•By Udhayaprakash and Karthik Anand Vijay
Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liquid... handling systems, and instruments; and bottles, carboys, measuring cylinder, cell culture products, electrophoresis, microscopy and microbiology products, vacuum desiccators, mini coolers, cryo boxes, utilities, test tube racks, PCR products, pipette tips, petri dish, centrifuge tubes, cryo vials, pasteur pipettes, and other products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India. Read more
Incorporated
1983
Chairman
Sanjive Sehgal
Managing Director
Sanjive Sehgal
Headquarters
Kolkata, West Bengal
Website
Looking for more details about Tarsons Products Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Tarsons Products Ltd is ₹201.08 (NSE) and ₹201.10 (BSE) as of 13-Apr-2026 IST. Tarsons Products Ltd has given a return of -28.85% in the last 3 years.
The P/E ratio of Tarsons Products Ltd is 52.59 times as on 13-Apr-2026, a 55 premium to its peers’ median range of 33.84 times.
The P/B ratio of Tarsons Products Ltd is 1.69 times as on 13-Apr-2026, a 42 discount to its peers’ median range of 2.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
53.92
|
2.55
|
|
2024
|
49.17
|
3.42
|
|
2023
|
35.12
|
4.98
|
|
2022
|
37.22
|
7.65
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Tarsons Products Ltd are Rs 458.00 and Rs 164.45 as of 13-Apr-2026.
Tarsons Products Ltd has a market capitalisation of ₹ 1,070 Cr as on 13-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Tarsons Products Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.